F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Full story
Read the full story at The New York Times - Politics ↗
Continue reading this story on The New York Times - Politics, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
